The Angioplasty Balloons Market has witnessed significant growth in recent years, Minimal invasive surgery has numerous advantages: less pain, swift recovery, smaller incisions, reduced hospital stay, and consequent medical costs. The rising geriatric population with the increasing prevalence of CVD will lead to the demand for minimally invasive treatment, which further propels the market's growth. As per the statistics published by Ageing Asia, the Vietnamese population aged 60 and above is projected to rise by 29,841,000 in 2050. Our comprehensive research report titled Angioplasty Balloons market offers a thorough analysis of the current market landscape and sheds light on the market trends, competitive dynamics, and growth opportunities. Also, it identifies the top players in the market and assesses their offerings, strategies, market share, and performance to help stakeholders make informed decisions and stay ahead of the competition.
Market Overview:
According to the research report published by Polaris Market Research, the global angioplasty balloons market was valued at USD 2.55 billion in 2021 and is expected to reach USD 3.44 billion by 2030, to grow at a CAGR of 3.4% during the forecast period.
Research Methodology:
Our research methodology combines qualitative and quantitative methods to offer a thorough analysis of the market. These research techniques used include:
Focus Groups: Includes qualitative data and insights into customer attitudes and opinions.
Surveys: Offers insights into consumer behavior, opinion, and interests.
Interviews: The study covers in-depth conversations with individuals to collect information about attitudes, beliefs, and motivations.
Secondary Research: The report analyzes existing data from reports, publications, and other credible sources.
All the information in the Angioplasty Balloons market research report goes through a multi-step verification method to ensure its accuracy and reliability.
List of Market Key Players:
The market has the presence of both established players and new entrants. These players are focusing on innovation and strategic partnerships to expand their global reach and increase their Angioplasty Balloons market share. Some of the key players in the market are:
Abbott Laboratories
AngioDynamics
B. Braun Melsungen AG.
Becton Dickinson
Biomerics
BIOTRONIK Vertriebs GmbH & Co. KG
Boston Scientific Corporation
Cardinal Health
Cordis (Cardinal Health)
CTK biotech
Inc
Hexacath
INFINITY Angioplasty Balloon
JOTEC GmbH
Koninklijke Philips N.V
Medtronic Plc
MicroPort Scientific Corporation
Nipro Medical Corporation
Overview of Top Companies:
Abbott Laboratories
Abbott Laboratories, founded in 1888 by Dr. Wallace C. Abbott, is a global healthcare company headquartered in Green Oaks, Illinois. The company operates in over 160 countries and employs approximately 114,000 individuals. Abbott's diverse portfolio includes diagnostics, medical devices, nutrition products, and branded generic pharmaceuticals. Notable products encompass Pedialyte, Similac, Ensure, Glucerna, FreeStyle Libre, and BinaxNOW. In 2023, Abbott reported revenues of $40.1 billion.
AngioDynamics
Established in 1988 and headquartered in Latham, New York, AngioDynamics is a medical technology company specializing in minimally invasive medical devices. The company's product offerings focus on vascular access, peripheral vascular disease treatment, and oncology. Key products include the AngioVac System for non-surgical removal of right heart vegetation, the AlphaVac System for mechanical aspiration, and the NanoKnife System for localized therapy. AngioDynamics operates globally, with a significant presence in the United States, and employs around 815 individuals.
Browse More Information:
Competitive Landscape:
The competitive landscape of the market is shaped by strategic partnerships and collaborations among Angioplasty Balloons market key players. These strategic initiatives are aimed at expanding their product portfolios and expanding their global reach. Companies like Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG., Becton Dickinson, Biomerics, BIOTRONIK Vertriebs GmbH & Co. KG, Boston Scientific Corporation, Cardinal Health, Cordis (Cardinal Health), CTK biotech, Inc, Hexacath, INFINITY Angioplasty Balloon, JOTEC GmbH, Koninklijke Philips N.V, Medtronic Plc, MicroPort Scientific Corporation, Nipro Medical Corporation are leveraging their global reach to cater to diverse consumer needs across various regions. Other players, such as Abbott Laboratories, AngioDynamics, B. Braun Melsungen AG., Becton Dickinson, Biomerics, are focusing on the incorporation of advanced technologies to improve their offerings. As the market evolves, the competition is set to intensify in the upcoming years.
Conclusion:
The Angioplasty Balloons market growth is poised to continue in the upcoming years. Companies adapting to shifting consumer preferences and technological innovations will continue to thrive in the evolving market landscape.
More Trending Latest Reports By Polaris Market Research:
Write a comment ...